Cite
HARVARD Citation
Jung, E. et al. (2019). ZNF133 is associated with infliximab responsiveness in patients with inflammatory bowel diseases. Journal of gastroenterology and hepatology. 34 (10), pp. 1727-1735. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jung, E. et al. (2019). ZNF133 is associated with infliximab responsiveness in patients with inflammatory bowel diseases. Journal of gastroenterology and hepatology. 34 (10), pp. 1727-1735. [Online].